Botanical species · safety record

Prunus mume

The EFSA Compendium of Botanicals holds 7 constituent measurements for Prunus mume. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Prunus mume (Siebold) Siebold & Zucc.

7Constituent measurements
0Safety records
5Cited sources
126Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 126 licensed products naming Prunus mume as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA

Source material stated

  • Dried fruit
  • Flower
  • Fruit
  • Fruit (roasted)
  • Ripe fruit(s)

What the records describe

Constituents measured

  • Benzaldehyde2
  • 3,4-dihydroxybenzaldehyde1
  • Amygdalin1
  • Cyanogenic glycosides1
  • Eugenol1
  • Prunasin1

Plant parts

  • Seed4
  • Fruit unspecified2
  • Unspecified1

Preparations

  • Solvent extraction4
  • Essential oil2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
3,4-dihydroxybenzaldehydeSeedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AmygdalinSeedSolvent extraction≤ 47 Gram/kilogramUnspecifiedNo resolvable identifier
BenzaldehydeUnspecifiedEssential oil62.4 PercentGC-MSNo resolvable identifier
BenzaldehydeSeedSolvent extraction1.9 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Cyanogenic glycosidesFruit unspecified45.87 Microgram/gramNo resolvable identifier
EugenolFruit unspecifiedEssential oil10.9 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
PrunasinSeedSolvent extraction≤ 10 Gram/kilogramUnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Kwon, Young Ju., Kim, Young Hoi., Kwag, Jae Jin., Kim, Kun Soo., Yang, Kwang Kyu. Volatile components of apricot (Prunus armeniaca var. ansu Max.) and Japanese apricot (Prunus mume Sieb. et Zucc.). Han'guk nonghwa hakhoechi, 1990, p. 319-324.
  2. Kameoka, Hiromu., Kitagawa, Chuji. Constituents of the fruits of Prunus mume Sieb. and Zucc. Nippon nogei kagaku kaishi, 1976, p. 389-393.
  3. OHTSUBO, T., IKEDA, F. SEASONAL-CHANGES OF CYANOGENIC GLYCOSIDES IN MUME (PRUNUS-MUME SIEB ET ZUCC) SEEDS . Journal of the japanese society for horticultural science, 1994, vol. 62, no. 4, p. 695-700.
  4. Kono, Ryohei., Nomura, Sachiko., Okuno, Yoshiharu., Nakamura, Misa., Maeno, Akihiro., Kagiya, Tomoko., Tokuda, Akihiko., Inada, Ken-ichi., Matsuno, Akira., Utsunomiya, Tomoko., Utsunomiya, Hirotoshi. 3,4-Dihydroxybenzaldehyde Derived from Prunus mume Seed Inhibits Oxidative Stress and Enhances Estradiol Secretion in Human Ovarian Granulosa Tumor Cells. ACTA HISTOCHEMICA ET CYTOCHEMICA, 2014, vol. 47, no. 3, p. 103-112. DOI
  5. Cho, Hye-Jeon., Do, Byung-Kyung., Shim, Soon-Mi., Kwon, Hoonjeong., Lee, Dong-Ha., Nah, Ahn-Hee., Choi, Youn-Ju., Lee, Sook-Yeon. Determination of cyanogenic compunds in edible plants by ion chromatography. Toxicological Research (Seoul, Republic of Korea), 2013, p. 143-147.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue